(1-303) Tolerability of Sacubitril/Valsartan in Heart Failure with Reduced Ejection Fraction Patients Receiving Hydralazine and Isosorbide Dinitrate

Sunday, December 4, 2022

3:30 PM – 5:00 PM

Location: Bayside A, Level 1

Category: Evaluative Study
Topic: Ambulatory Care

Co-Author(s): Meredith Sigler, Krystal Edwards, Rick Weideman, Carlos Alvaraez

Primary Author(s)

Molly E. Steeves, PharmD
PGY2 Ambulatory Care Resident
VA North Texas Health Care System, Texas